# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Michelangelo Buonarroti (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE002-SYN
- Date: 2026-10-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Serena Castellano, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Hand osteoarthritis and gout review at about seven months. **S**

## History of present illness

Mr. Buonarroti returns about seven months after his first visit and five weeks after his wellness visit. His hand pain stays about 3 of 10. He carves three to four hours most mornings with the splint and padded tools and writes his own letters again, if slowly. He takes acetaminophen 1 g on most days and the gel once or twice a day. He has had no gout flare, no urinary symptoms, and no falls. His DXA is booked for next week. **S**

| Element | Detail |
|---|---|
| Pain | About 3 of 10 |
| Function | Carving three to four hours most mornings; writes his own letters |
| Analgesics | Acetaminophen about 1 g a day; gel once or twice a day; no oral NSAIDs |
| Gout and stones | No flare or stone |
| Falls | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Mild left thumb-base ache after long sessions; no swollen joints or foot pain |
| Genitourinary | Negative | No flank pain, blood in the urine, or straining |
| Gastrointestinal | Negative | No indigestion or dark stools |

3 systems reviewed. **S**

## Current medications

- Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily **S**
- Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either hand **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/76 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 61.6 kg; BMI 21.8 kg/m². All vital signs are synthetic.

Serum urate: 5.2 mg/dL; Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 19 mg/dL; Creatinine: 1 mg/dL; eGFR: 74 mL/min/1.73 m²; Glucose: 94 mg/dL; ALT: 17 U/L; Hand pain (0-10 numeric rating): 3; PROMIS upper extremity T-score: 43; Grip strength, left hand: 18 kg; Grip strength, right hand: 23 kg. All results are synthetic.

## Change since baseline

- Serum urate: 5.4 mg/dL at baseline, 5.2 mg/dL at this visit **S**
- Sodium: 138 mmol/L at baseline, 140 mmol/L at this visit **S**
- Potassium: 4.9 mmol/L at baseline, 4.4 mmol/L at this visit **S**
- Bicarbonate (total CO2): 24 mmol/L at baseline, 25 mmol/L at this visit **S**
- BUN: 26 mg/dL (high) at baseline, 19 mg/dL at this visit **S**
- Creatinine: 1.21 mg/dL at baseline, 1 mg/dL at this visit **S**
- eGFR: 59 mL/min/1.73 m² (low) at baseline, 74 mL/min/1.73 m² at this visit **S**
- Glucose: 92 mg/dL at baseline, 94 mg/dL at this visit **S**
- ALT: 18 U/L at baseline, 17 U/L at this visit **S**
- Hand pain (0-10 numeric rating): 7 at baseline, 3 at this visit **S**
- PROMIS upper extremity T-score: 33 at baseline, 43 at this visit **S**
- Grip strength, left hand: 14 kg at baseline, 18 kg at this visit **S**
- Grip strength, right hand: 22 kg at baseline, 23 kg at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Left hand | Thumb-base squaring with slight tenderness; no synovitis; thumb abduction a little better than in the spring |
| Right hand | Heberden nodes; no synovitis |
| Feet | No tophi or swelling |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Left hand osteoarthritis** (M19.042). Sustained improvement six months after the injection: pain 3 of 10, PROMIS upper extremity T-score 43, left grip 18 kg. ALT 17 U/L on regular acetaminophen. **S**
   - Continue the current plan.
   - Review every six months, sooner if pain rises above 5 of 10.
2. **Right hand osteoarthritis** (M19.041). Mild and stable. **S**
   - Gel as needed.
3. **Gout** (M1A.9XX0). Serum urate 5.2 mg/dL on allopurinol 200 mg; creatinine 1.00 mg/dL, eGFR 74. **S**
   - Continue allopurinol 200 mg daily.
   - Serum urate in six months.
4. **History of urinary stones** (Z87.442). Stone-free. **S**
   - Continue about 2 L of water a day.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Hand pain, 0 to 10 numeric rating | Each clinical encounter; after each therapeutic trial | Completed today | 3 of 10 |
| Survey | Validated function measure (PROMIS upper extremity T-score; AUSCAN and FIHOA have no LOINC code) | Each clinical encounter | Completed today | T-score 43 (population mean 50; higher is better) |
| Examination | Grip strength by dynamometer | Each clinical encounter in this plan | Completed today | Left 18 kg, right 23 kg |
| Examination | Joint examination | Each clinical encounter | Completed today | No synovitis; slight thumb-base tenderness |
| Laboratory | ALT on regular acetaminophen | Periodically, especially near 3 g a day | Completed today | 17 U/L |
| Laboratory | Serum urate | Every 6 months at target | Completed today | 5.2 mg/dL: at target |
| Laboratory | Creatinine and eGFR for allopurinol dosing and analgesic safety | Every 6 to 12 months | Completed today | Creatinine 1.00 mg/dL, eGFR 74; potassium 4.4 mmol/L |
| Medication safety | Analgesic review: no oral NSAIDs; acetaminophen dose | Each clinical encounter | Completed today | No ibuprofen; acetaminophen about 1 g a day |
| Imaging | Hand radiographs | Not for routine follow-up | Not indicated | Clinical improvement; no repeat imaging |
| Survey | Mood, sleep, and coping screen | Periodically | Up to date | PHQ-2 score 0 at the September wellness visit |
| Self-management | Exercise, joint protection, and splint use | Each clinical encounter | Completed today | Daily exercises; splint for carving |
| Self-management | Gait, balance, and falls | Ongoing | Up to date | No falls; Timed Up and Go 11 seconds in September; DXA booked next week |
| Self-management | Fluid intake for stone prevention | Each clinical encounter | Completed today | About 2 L of water a day |

## Goal progress

- Hand pain at or below 3 of 10 on most days by the seven-month review. Outcome by 2026-10-19: Pain 3 of 10, down from 7. **S**
- Carve for at least three hours a morning and write his own letters. Outcome by 2026-10-19: Carving three to four hours most mornings; writes short letters with a thick-barrelled pen. **S**
- No oral NSAID use and creatinine back to his baseline. Outcome by 2026-04-13: Ibuprofen stopped; creatinine from 1.21 to 1.02 mg/dL. **S**
- Serum urate below 6 mg/dL and no gout flare or stone. Outcome by 2026-10-19: Urate 5.2 mg/dL; no flare or stone. **S**
- No falls, with safe ladder and scaffold use. Outcome by 2026-10-19: No falls; he uses a platform ladder with a rail and does not climb alone. **S**

## Guideline basis

- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Rheumatol 2020;72(2):220-233)
- 2020 American College of Rheumatology Guideline for the Management of Gout (2020), American College of Rheumatology (Arthritis Care Res 2020;72(6):744-760)
- Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019), American Urological Association
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (J Am Geriatr Soc 2023;71(7):2052-2081)
- CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis monograph (2026), Aether Forge
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- Osteoporosis to Prevent Fractures: Screening (2025), U.S. Preventive Services Task Force

## Follow-up

- DXA next week, with a call about the result. Hand and gout review in six months with serum urate. **S**

